Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Opdivo Multiple Myeloma Clinical Trials Halted Following Keytruda Deaths September 8, 2017 Russell Maas Add Your Comments Federal health officials have placed a hold on three clinical trials designed to test the combination of advanced lung cancer treatments with various other forms of cancer drugs for treatment of multiple myeloma, after reports of several patient deaths with a similar drug. Bristol-Myers Squibb issued a press release on September 6, announcing that the FDA has halted the studyes that were testing Opdivo in conjunction with Celgene’s Revlimid or Pomalyst medications, which are the same medications used in conjunction with Keytruda multiple myeloma studies that resulted in several patient deaths. Opdivo and Keytruda are similar, competing cancer drugs known as immune checkpoint inhibitors. Multiple myeloma is a form blood cancer related to lymphoma and leukemia, in which Merck’s Keytruda and Bristol-Myers Squibb’s Opdivo were being tested in separate clinical trials, pairing them with the chemotherapy drug dexamethasone and either Celgene’s Revlimid or Pomalyst, as a potential new form of treatment. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Following patient deaths in two Keytruda clinical studies, the FDA halted any further advancement and new patient registration for both companies, out of an abundance of caution. The agency said the risks of severe adverse events, including death, appeared to outweigh any benefits of using the drug combinations to treat multiple myeloma. The Opdivo trials are being halted due to the close similarities between Keytruda and Opdivo. The FDA is ordering patients currently taking part in the Opdivo trials to continue with the regimens, as long as they are experiencing clinical benefit. However, no new patients can enroll in the studies. Opdivo studies affected by the FDA’s decision include CheckMate-602, CheckMate-039, and CA204142. The FDA previously issued a safety alert for two Keytruda studies on August 31, 2017 after finding the medication used in combination with some other medications to treat multiple myeloma may be deadly for some patients. The FDA warning came after data from the KEYNOTE-183 trial, which involved about 250 patients, indicated that patients given Keytruda had a 61% increased risk of death, with 29 deaths in the Keytruda arm of the clinical trial, compared to only 21 deaths among the control subjects. Furthermore, the Keytruda KEYNOTE-185 clinical trial, involving about 300 patients, saw an even higher risk, with more than twice as many Keytruda patients dying than those in the control group, 19 to 9. That trial also showed that 54% of the patients given a Keytruda-based drug combination had a 54% chance of severe adverse health effects, compared to only 39% in the control group. The FDA is asking healthcare professionals and patients who experience any adverse events or side effects during Keytruda treatment to report them to the FDA’s MedWatch Adverse Event Reporting Program. Written by: Russell Maas Managing Editor & Senior Legal Journalist Russell Maas is a paralegal and the Managing Editor of AboutLawsuits.com, where he has reported on mass tort litigation, medical recalls, and consumer safety issues since 2010. He brings legal experience from one of the nation’s leading personal injury law firms and oversees the site’s editorial strategy, including SEO and content development. Tags: Bristol Myers Squibb, Cancer, Clinical Trials, Keytruda, Merck, Multiple Myeloma, Opdivo More Lawsuit Stories Wayfair Fire Pit Lawsuit Links Flame Jetting Explosion to Defective Design September 5, 2025 Woman Files Trulicity and Ozempic Lawsuit Over Ileus, Intestinal Obstruction September 5, 2025 Cigarette Smoke May Accelerate Silicosis Risks: Study September 5, 2025 4 Comments Sue May 2, 2020 In 2012 my husband was diagnosed with Renal Cell Carsanoma for which there is no chemo treatment. In 2019 he was told by his Oncologist that he may want to consider immuno therapy and after one infusion of Opdivo the drug started to attack all his vital organs and ultimately caused his death in May 2019. We were not told at the time of treatment that this drug was so new that even the doctors did not know how to reverse the horrific side effects. They were brutal!! I feel my husband would still be alive today if he had not taken Opdivo!!! His Oncologist agreed that his cancer was not what he died from it was that toxic drug. Sharon January 30, 2020 My husband was scheduled for 26 treatments after # 4 shut down his pituitary gland , almost killed him. Now has lifelong effects from this drug. Use extreme caution when advised to take this as a treatment. Debra July 25, 2019 On the fourth day after my husband’s second Opdivo infusion, he was in the hospital with a glucose reading of 1,100. He is now a type 1 diabetic and has had severe diarrhea for over 5 months. Please do not take this drug. It has life altering consquences. cv September 26, 2017 I am gut sick about this treatment. My husband had two chemo treatments and then was changed to Opdivo. It was not clinical trial. Why on earth would a pharm. company allow their drug to be given to someone without a spleen, since it works with your immune system. They did not think twice about helping with funding, do they educate the doctors. There is no doubt in my mind, my husband would still be here if not for the side effects and lack of information given to us on this drug. Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermFacebookThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Wayfair Fire Pit Lawsuit Links Flame Jetting Explosion to Defective Design (Posted: today) In March 2026, a jury is scheduled to hear a Wayfair fire pit lawsuit from a woman who suffered burns to nearly half her body. MORE ABOUT: TABLETOP FIRE PIT LAWSUITAmazon Tabletop Fire Pit Lawsuit Alleges ‘Flame-Jetting’ Caused Third Degree Burns (08/29/2025)Tabletop Fire Pit Burn Victims Share Stories of Explosions and Devastating Injuries (08/21/2025)Colsen Fire Pit Lawsuit Involving Severe Burn Injuries Suffered by a Child Set for Trial Next Year (08/14/2025) Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (Posted: yesterday) Dupixent lawsuits are now being investigated after studies and FDA reports link Dupixent (dupilumab) to cutaneous T-cell lymphoma (CTCL). MORE ABOUT: DUPIXENT LAWSUITDupixent Side Effects May Increase Cutaneous T-Cell Lymphoma (CTCL) Risks (08/26/2025) Depo-Provera Meningioma Side Effects Significantly Increased Among Women Over 31: Study (Posted: 2 days ago) A new study appears to further confirm and quantify the risks of Depo-Provera meningioma side effects, potentially providing further evidence for growing litigation. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Seeks Dismissal of Depo-Provera Failure-To-Warn Lawsuits Over Meningioma Risks (09/02/2025)Nearly 1,000 Depo-Provera Meningioma Lawsuits Filed, With Another 9,500 Under Investigation (08/25/2025)Experts Weigh In On Depo-Provera Brain Tumor Risks, As Lawsuits Continue to Mount (08/20/2025)
Wayfair Fire Pit Lawsuit Links Flame Jetting Explosion to Defective Design (Posted: today) In March 2026, a jury is scheduled to hear a Wayfair fire pit lawsuit from a woman who suffered burns to nearly half her body. MORE ABOUT: TABLETOP FIRE PIT LAWSUITAmazon Tabletop Fire Pit Lawsuit Alleges ‘Flame-Jetting’ Caused Third Degree Burns (08/29/2025)Tabletop Fire Pit Burn Victims Share Stories of Explosions and Devastating Injuries (08/21/2025)Colsen Fire Pit Lawsuit Involving Severe Burn Injuries Suffered by a Child Set for Trial Next Year (08/14/2025)
Dupixent T-Cell Lymphoma Lawsuits May Follow Recent Studies Linking Drug to Cancer Risks (Posted: yesterday) Dupixent lawsuits are now being investigated after studies and FDA reports link Dupixent (dupilumab) to cutaneous T-cell lymphoma (CTCL). MORE ABOUT: DUPIXENT LAWSUITDupixent Side Effects May Increase Cutaneous T-Cell Lymphoma (CTCL) Risks (08/26/2025)
Depo-Provera Meningioma Side Effects Significantly Increased Among Women Over 31: Study (Posted: 2 days ago) A new study appears to further confirm and quantify the risks of Depo-Provera meningioma side effects, potentially providing further evidence for growing litigation. MORE ABOUT: DEPO-PROVERA LAWSUITPfizer Seeks Dismissal of Depo-Provera Failure-To-Warn Lawsuits Over Meningioma Risks (09/02/2025)Nearly 1,000 Depo-Provera Meningioma Lawsuits Filed, With Another 9,500 Under Investigation (08/25/2025)Experts Weigh In On Depo-Provera Brain Tumor Risks, As Lawsuits Continue to Mount (08/20/2025)